Home › Funds › Caligan Partners LP › FTH

Caligan Partners LP position in FTH

FAETH THERAPEUTICS INC

Caligan Partners LP reported holding 629,467 shares of FTH (FAETH THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$15.7M, representing 0.92% of its reported portfolio and ranking #21 among its reported holdings. Caligan Partners LP has disclosed FTH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)629.47K sh
Reported value held$15.74M
Portfolio Weight0.92%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Caligan Partners LP's FTH position evolved

Caligan Partners LP first disclosed a stake in FTH in Q1 2026 at 126,002 shares (US$4.0M). The position peaked in Q2 2026 at 629,467 shares, worth US$15.7M. Across 2 filings, Caligan Partners LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 629,467 shares valued at US$15.7M — an increase of 503,465 shares quarter over quarter.. Notable position changes include a 400% increase in Q2 2026 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 126.00K $3.97M New
Q2 2026 629.47K $15.74M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About FTH and 13F data

FTH (FAETH THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 46 other funds we track also report a position in FTH — the largest reported positions include MONTANOVA CAPITAL, LLC (US$50.5M), Avoro Capital Advisors LLC (US$36.1M), BAKER BROS. ADVISORS LP (US$32.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding FTH

All FTH fund holders →

FAQ

How long has Caligan Partners LP held FTH?

Caligan Partners LP has disclosed FTH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Caligan Partners LP's current position in FTH?

As of Q2 2026, Caligan Partners LP holds 629.47K shares of FTH (FAETH THERAPEUTICS INC), valued at $15.74M, representing 0.92% of its reported portfolio and ranking #21.

Has Caligan Partners LP been buying or selling FTH?

In the latest 13F filing (Q2 2026), Caligan Partners LP increased its position in FTH. The position peaked in Q2 2026 at 629.47K shares.

Which other funds hold FTH?

Other major institutional holders of FTH include MONTANOVA CAPITAL, LLC, Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.